Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000226343 | SCV000283484 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722205 | SCV000512708 | likely benign | not provided | 2020-03-30 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659451 | SCV000781266 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000226343 | SCV002554217 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270028 | SCV002554218 | benign | Fibromuscular dysplasia, multifocal | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955296 | SCV004766866 | benign | COL5A1-related disorder | 2019-03-07 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987463 | SCV004803341 | benign | not specified | 2024-01-15 | criteria provided, single submitter | clinical testing |